BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1263@pharmaconomics
DTSTAMP:20260707T030840Z
DTSTART;VALUE=DATE:20260101
DTEND;VALUE=DATE:20260102
SUMMARY:MOLN Phase 1 — MP0712 (estimated date)
DESCRIPTION:Phase 1 trial results for MP0712 in small cell lung cancer are due ~ Jan 1\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1745114/000174511426000012/annualreport2025.htm\n\nTrack it: https://pharmaconomics.com/e/1263
URL:https://pharmaconomics.com/e/1263
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:MOLN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR